FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017264871> ?p ?o ?g. }

• W2017264871 endingPage "C395" @default.
• W2017264871 startingPage "C389" @default.
• W2017264871 abstract "This study investigated the acute effects of a peroxisome proliferator-activated receptor (PPAR)-gamma ligand, ciglitizone, on cell proliferation and intracellular Ca2+ signaling in human normal myometrium and uterine leiomyoma. Changes in intracellular Ca2+ concentration ([Ca2+]i) were measured with fura-2 AM, and cellular viabilities were determined by viable cell count and 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide reduction assay. Ciglitizone (100 microM) induced greater inhibition of cell proliferation in uterine leiomyoma than in myometrium. Ciglitizone also dose-dependently increased [Ca2+]i in both myometrium and uterine leiomyoma; these [Ca2+]i increases were inhibited by PPAR-gamma antagonists and raloxifene. Ciglitizone-induced [Ca2+]i increase showed only an initial peak in normal myometrial cells, whereas in uterine leiomyoma there was a second sustained [Ca2+]i increase as well. The initial [Ca2+]i increase in both myometrium and uterine leiomyoma resulted from the release of Ca2+ by the sarcoplasmic reticulum via activation of ryanodine receptors. The second [Ca2+]i increase was observed only in uterine leiomyoma because of a Ca2+ influx via an activation of store-operated Ca2+ channels (SOCCs). Cell proliferation was inhibited and secondary [Ca2+]i increase in uterine leiomyoma was attenuated by cotreatment of ciglitizone with a SOCC blocker, lanthanum. The results suggest that ciglitizone inhibits cell proliferation and increases [Ca2+]i through the activation of SOCCs, especially in human uterine leiomyoma." @default.
• W2017264871 created "2016-06-24" @default.
• W2017264871 creator A5002079257 @default.
• W2017264871 creator A5006756677 @default.
• W2017264871 creator A5011356826 @default.
• W2017264871 creator A5017086105 @default.
• W2017264871 creator A5023771868 @default.
• W2017264871 creator A5027056830 @default.
• W2017264871 creator A5034255213 @default.
• W2017264871 creator A5038680697 @default.
• W2017264871 creator A5043404678 @default.
• W2017264871 creator A5061796375 @default.
• W2017264871 creator A5063502416 @default.
• W2017264871 creator A5084096069 @default.
• W2017264871 date "2005-02-01" @default.
• W2017264871 modified "2023-10-18" @default.
• W2017264871 title "Ciglitizone inhibits cell proliferation in human uterine leiomyoma via activation of store-operated Ca²⁺ channels" @default.
• W2017264871 cites W1505047300 @default.
• W2017264871 cites W1599277155 @default.
• W2017264871 cites W1784820495 @default.
• W2017264871 cites W1925149569 @default.
• W2017264871 cites W1977666051 @default.
• W2017264871 cites W1978509804 @default.
• W2017264871 cites W1980794984 @default.
• W2017264871 cites W1993342645 @default.
• W2017264871 cites W2000708353 @default.
• W2017264871 cites W2003197964 @default.
• W2017264871 cites W2022732160 @default.
• W2017264871 cites W2027778427 @default.
• W2017264871 cites W2033737472 @default.
• W2017264871 cites W2039373487 @default.
• W2017264871 cites W2049779407 @default.
• W2017264871 cites W2061000653 @default.
• W2017264871 cites W2064363789 @default.
• W2017264871 cites W2070832223 @default.
• W2017264871 cites W2082597621 @default.
• W2017264871 cites W2083461125 @default.
• W2017264871 cites W2085603542 @default.
• W2017264871 cites W2088154205 @default.
• W2017264871 cites W2106450957 @default.
• W2017264871 cites W2113628341 @default.
• W2017264871 cites W2114366598 @default.
• W2017264871 cites W2116669059 @default.
• W2017264871 cites W2125344994 @default.
• W2017264871 cites W2130035339 @default.
• W2017264871 cites W2264069562 @default.
• W2017264871 cites W2340070178 @default.
• W2017264871 cites W4236251968 @default.
• W2017264871 doi "https://doi.org/10.1152/ajpcell.00154.2004" @default.
• W2017264871 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15469956" @default.
• W2017264871 hasPublicationYear "2005" @default.
• W2017264871 type Work @default.
• W2017264871 sameAs 2017264871 @default.
• W2017264871 citedByCount "16" @default.
• W2017264871 countsByYear W20172648712012 @default.
• W2017264871 countsByYear W20172648712013 @default.
• W2017264871 countsByYear W20172648712017 @default.
• W2017264871 countsByYear W20172648712020 @default.
• W2017264871 crossrefType "journal-article" @default.
• W2017264871 hasAuthorship W2017264871A5002079257 @default.
• W2017264871 hasAuthorship W2017264871A5006756677 @default.
• W2017264871 hasAuthorship W2017264871A5011356826 @default.
• W2017264871 hasAuthorship W2017264871A5017086105 @default.
• W2017264871 hasAuthorship W2017264871A5023771868 @default.
• W2017264871 hasAuthorship W2017264871A5027056830 @default.
• W2017264871 hasAuthorship W2017264871A5034255213 @default.
• W2017264871 hasAuthorship W2017264871A5038680697 @default.
• W2017264871 hasAuthorship W2017264871A5043404678 @default.
• W2017264871 hasAuthorship W2017264871A5061796375 @default.
• W2017264871 hasAuthorship W2017264871A5063502416 @default.
• W2017264871 hasAuthorship W2017264871A5084096069 @default.
• W2017264871 hasBestOaLocation W20172648712 @default.
• W2017264871 hasConcept C113217602 @default.
• W2017264871 hasConcept C126322002 @default.
• W2017264871 hasConcept C134018914 @default.
• W2017264871 hasConcept C142724271 @default.
• W2017264871 hasConcept C158617107 @default.
• W2017264871 hasConcept C170493617 @default.
• W2017264871 hasConcept C181199279 @default.
• W2017264871 hasConcept C185592680 @default.
• W2017264871 hasConcept C2777795800 @default.
• W2017264871 hasConcept C2778164554 @default.
• W2017264871 hasConcept C2778470358 @default.
• W2017264871 hasConcept C2779066055 @default.
• W2017264871 hasConcept C3017725331 @default.
• W2017264871 hasConcept C55493867 @default.
• W2017264871 hasConcept C62112901 @default.
• W2017264871 hasConcept C71924100 @default.
• W2017264871 hasConcept C79879829 @default.
• W2017264871 hasConcept C86803240 @default.
• W2017264871 hasConcept C98539663 @default.
• W2017264871 hasConceptScore W2017264871C113217602 @default.
• W2017264871 hasConceptScore W2017264871C126322002 @default.
• W2017264871 hasConceptScore W2017264871C134018914 @default.
• W2017264871 hasConceptScore W2017264871C142724271 @default.
• W2017264871 hasConceptScore W2017264871C158617107 @default.
• W2017264871 hasConceptScore W2017264871C170493617 @default.
• W2017264871 hasConceptScore W2017264871C181199279 @default.

• next